Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04714840 · ClinicalTrials.gov registry record · NA

Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise Tolerance

A NA study of Mobility Limitation and Childhood Cancer, sponsored by St. Jude Children's Research Hospital.

Active
Registry status
NA
Development phase
181
Enrollment target
1
Study location

NCT04714840: Active NA study of Mobility Limitation and Childhood Cancer, sponsored by St. Jude Children's Research Hospital.

NCT04714840 is a NA study of Mobility Limitation and Childhood Cancer that is active but no longer recruiting, run by St. Jude Children's Research Hospital. The registered enrollment target is 181 participants, below the 249-participant average among 28 other Mobility Limitation trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04714840, a NA study of Mobility Limitation and Childhood Cancer, is active but no longer recruiting, sponsored by St. Jude Children's Research Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
181 participants
Enrollment target
1
Study location

Study Summary

The participants are asked to take part in this clinical trial, a type of research study. The participants are SJLIFE study participants and may have a hard time exercising (exercise intolerance) due to side effects of cancer treatment received as a child.This study is being done to determine if a personalized exercise plan will help childhood cancer survivors who have exercise intolerance become more active. Primary Objectives: To achieve the goal of this study, we propose the following three Objectives: Primary Objective 1: To determine the efficacy of an individually tailored, home-delivered aerobic and strengthening intervention to improve exercise capacity in survivors of childhood cancer with exercise intolerance (peak oxygen uptake (peak VO2) \<85% of age and sex predicted). Primary Objective 2: To determine the effects of an individually tailored, home-delivered aerobic and strengthening intervention on measures of cardiac, pulmonary, musculoskeletal, and neurosensory function in survivors of childhood cancer with exercise intolerance. Primary Objective 3: To determine the effects of an individually tailored, home-delivered aerobic and strengthening intervention on emotional health, participation in family and community activities, quality of life, and cognitive function in survivors of childhood cancer with exercise intolerance.

Primary Outcome

Changes in Peak VO2/2-minute step in place test in both INT and AC groups

Interventions

  • OTHER Exercise testing results
  • OTHER Individually tailored exercise program (INT)
  • OTHER Generalized exercise recommendations (AC)

Study Locations (1)

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 181 participants
Start Date 2021-02-08
Est. Completion 2026-03-01
Phase NA

What the registry record for NCT04714840 still lists

NCT04714840 is an interventional study that assigns participants to a tested intervention. The registered 181 participants enrollment target is mid-sized for trials with a published cap, below the 249-participant average among 28 other Mobility Limitation trials with a reported enrollment target (27% lower).

The record links to 2 conditions, with Mobility Limitation appearing as the primary indexed condition, and to 3 interventions - of which Exercise testing results is the first listed.

NCT04714840 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT04714840 about?

NCT04714840 is a clinical study titled "Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise Tolerance". The participants are asked to take part in this clinical trial, a type of research study. The participants are SJLIFE study participants and may have a hard time exercising (exercise intolerance) due to side effects of cancer treatment received as a child.This study is being done to determine if a p...

What is the current status of trial NCT04714840?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 181 participants. The study started on 2021-02-08. Estimated completion is 2026-03-01.

What conditions does trial NCT04714840 study?

This clinical trial studies the following conditions: Mobility Limitation, Childhood Cancer.

What interventions are being tested in trial NCT04714840?

The interventions under investigation include: Exercise testing results (OTHER), Individually tailored exercise program (INT) (OTHER), Generalized exercise recommendations (AC) (OTHER).

Who is sponsoring clinical trial NCT04714840?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04714840 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mobility Limitation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04714840's enrollment target sits among peer trials

181 9th of 28 higher than 20 of 28 other Mobility Limitation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mobility Limitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04578392 · 181 participants · NA

    MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)

  • NCT05597891 · 181 participants · NA

    Endovascular Engineering ENGULF Study

  • NCT03897998 · 182 participants · Phase 2

    Neural Correlates of Hypoalgesia Driven by Observation

  • NCT04300556 · 182 participants · Phase 1

    A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04714840, the US trial registry maintained by the National Library of Medicine. NCT04714840 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.